Patents by Inventor Daniel L. Weeks

Daniel L. Weeks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Positively charged oligonucleotides as regulators of gene expression
    Patent number: 6331617
    Abstract: This invention relates to oligonucleotides with cationic phosphoramidate internucleoside linkages useful for binding to nucleic acid to inhibit or alter gene expression.
    Type: Grant
    Filed: March 27, 1998
    Date of Patent: December 18, 2001
    Assignee: University of Iowa Research Foundation
    Inventors: Daniel L. Weeks, John Dagle
  • Oligonucleotides with cationic phosphoramidate internucleoside linkages and methods of use
    Patent number: 6274313
    Abstract: This invention relates to the use of oligonucleotides with cationic phosphoramidate internucleoside linkages for the identification of nucleic acid under DNA—DNA duplex denaturing conditions.
    Type: Grant
    Filed: March 27, 1998
    Date of Patent: August 14, 2001
    Assignees: Pioneer-Hybrid International, Inc., University of Iowa Research Foundation
    Inventors: Daniel L. Weeks, John Dagle, John G. K. Williams
  • Positively charged oligonucleotides as regulators of gene expression
    Patent number: 5734040
    Abstract: This invention relates to oligonucleotides with ethylenediamine phosphoramidate internucleoside linkages useful for binding to eukaryotic duplex DNA to inhibit or alter gene expression.
    Type: Grant
    Filed: March 21, 1996
    Date of Patent: March 31, 1998
    Assignee: University of Iowa Research Foundation
    Inventors: Daniel L. Weeks, John Dagle